BridgeBio Pharma plans to offer $500 million in convertible senior notes, aiming to strengthen its financial position and reduce interest expenses. BridgeBio Pharma, Inc. announced plans to offer $500 ...
THIS volume is a collection of bulletins published monthly by the Technical Instruction Committee of the Essex County Council, as an aid to the teaching of biology. It contains information bearing ...
BridgeBio Pharma, Inc. has announced the pricing of $500 million in convertible senior notes at a 1.75% interest rate, maturing in 2031, in a private offering aimed at qualified institutional buyers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results